Nano News
Looking inside Nanolive
Join Nanolive at the ASCB|EMBO meeting 2022, Washington D.C.!
Nanolive will be present at the ASCB|EMBO meeting this year in Washington D.C., from the 3rd to the 7th of December, where we’ll be showcasing our vast range of label-free high content phenotypic solutions, that combine screening, imaging, and analysis to radically...
Nanolive featured in a Nature Protocols paper as part of a new methodology for efficient and safe single-cell cloning
We congratulate Carlos Tristan, Ilyas Singeç, and the Stem Cell Translation Laboratory team at the National Institutes of Health, USA, on their newly published protocol for single cell cloning; ‘Efficient and safe single-cell cloning of human pluripotent stem cells...
Investigating the morphology and branching properties of serotonergic axons
Dr. Skirmantas Janusonis’s lab, located in the Psychological & Brain Sciences Department of the University of California, Santa Barbara, focuses on the deep structure and dynamics of the brain serotonin matrix. Graduate student, Melissa Hingorani, used Nanolive...
17 new scientific publications featuring Nanolive live cell data solutions
Wow, our clients have been busy this year! Here are another 17 publications covering a range of topics, from drug discovery to immuno-oncology and nanoparticles to stem cells. A non-canonical vitamin K cycle is a potent ferroptosis suppressor, by Mishima et al. was...
Nanolive launches the LIVE Cell Death Assay
A push-button, automated solution for profiling cell health and death Nanolive launches another ground-breaking tool in cell analysis: the LIVE Cell Death Assay, a push button, automated solution for profiling cell health, death, apoptosis and necrosis, label-free....
Exploring the potential Nanolive technology holds for phenotypic drug discovery
We are very proud and excited to announce a new publication from Dr. José Padrón and lead author Adrián Puerta showing the benefits of using Nanolive’s label-free data analysis in Phenotypic Drug Discovery (PPD) programs. Dr. Padrón is a Professor at the Universidad...
The Smart Lipid Droplet Assay: what do Key Opinion Leaders say about it?
For the launch of our new digital assay, the Smart Lipid Droplet Assay, several key opinion leaders from various pharmaceutical companies and institutions had the chance to try out Nanolive's new tool first hand. Check below how they’ve put the new tool to use, and...
15 Scientific publications featuring Nanolive live cell imaging
We are excited to announce 15 new articles featuring Nanolive technology have been published this year. The broad spectrum of journals including @Nanotoday, @Ongogene, @Advanced Healthcare Materials, @Science Advances, and @eLife, reflect the growing impact we are...
Nanolive launches the Smart Lipid Droplet Assay LIVE
High precision segmentation of lipid droplets in cells label-free Nanolive launches another ground-breaking solution in cell analysis: the Smart Lipid Droplet Assay, the first push button solution for analyzing lipid droplets dynamics, label-free. The Smart Lipid...
Testimonial: The Live T Cell Assay has the potential to revolutionize biopharmaceutical research
David Agorku was the lucky winner of a competition that we ran last year offering pharma and biotech companies the chance to win the use of a CX-A for 6 months. David’s goal is to understand how T cells and fibroblast cells interact, so we provided him with a CX-A...
Nanolive – our story
Nanolive Nanolive delivers breakthrough imaging solutions that combine screening, imaging, and analysis to radically advance how scientists study living cells and provide novel biological insights into the mechanisms of cancer and neurodegenerative diseases. Our...
Feature Application: Calculating kinetic EC50 values from dose-response curves
Introduction Dose-response curves provide important pharmacodynamic properties (efficacy, potency, toxicity, and lethality) for evaluating the performance of candidate drugs in the discovery pipeline. Half maximal effective concentration (EC50) values are a standard...
Webinar: Generating kinetic EC50 values using label-free cytotoxicity assays
In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine. Specifically, Dr. Gibbin-Lameira will show that: Dose-dependent experiments can be...
Article: Staurosporine-induced cell death
Staurosporine: the protein kinase inhibitor that packed a powerful punch Staurosporine is a powerful antiproliferative agent that inhibits tumor cell growth by inducing cell death via intrinsic apoptotic pathways. Discovered in a soil sample in 1977 by scientists from...
A chronicle through the eras and discoveries of cancer research. How is Nanolive contributing with their innovations?
Cancer A word pernicious enough to make your blood run cold. And one that 19.3 million people have the misfortune to hear every year. Cancer has the unenviable crown of being the leading cause of death worldwide, claiming more than 10 million lives in 2020 alone....
Shining a spotlight on Nanolive research in Belgium
Earlier in the year we published a blogpost highlighting some of the incredible on-going research that Nanolive users in Spain and Portugal are conducting (here), and now it’s Belgium’s turn! Over the next couple of months, we will be updating this page with some of...
18 Scientific publications featuring Nanolive live cell imaging
2021 has been a productive publishing year for owners of Nanolive microscopes, with another 18 since our last update in June (see here). The broad range of topics covered this time highlights the versatility of our technology and the creativity of our clients – from...
Take a tea break with Emma and discover how to quantify cell cytotoxicity in 96 WP format label-free
Our last live virtual event of 2021: a quick scientific tea break with Communication Specialist Dr. Emma Gibbin-Lameira, is now available on demand! Watch as Dr. Gibbin-Lameira presents a powerful cytotoxicity case study showing Nanolive’s unique live cell-based...